Skip to main content

More on NIH funding

Here's another story about NIH funding from the American Thoracic Society's Washington Letter.

House Approves 2010 Health Spending Bill

On July 24, the House passed the FY 2010 health research and services spending bill, known as the Labor-HHS-Education Appropriations Bill. The House passed the bill by a margin of 264 to 153. The bill provides $30.966 billion for NIH, a 3.1 percent increase over FY 2009 and a 1 percent increase for the CDC.

The bill includes language requesting the CDC establish a program, including a public health action plan, on COPD, although funding has not yet been specified. The ATS is working with CDC's Office of Chronic Disease Prevention and members of Congress to ensure that a COPD public health program will be set up within the next year. The ATS was also successful in getting the following other agency directives included in the bill:
• Directive applauding NHLBI's sleep research and calling for more study to modify the link between sleep disorders and cardiovascular disease.
• Directive urging the NIAID to intensify research into new diagnostics, drugs and vaccines to halt the spread of drug-resistant TB.
• Directive to CDC TB program grantees calling for minimal administrative costs to ensure adequate funding to all jurisdictions based on proportion and complexity of TB cases.

The House passed an amendment to the Labor-HHS bill offered by Rep. Issa (R-CA) to prohibit NIH from funding three peer-reviewed grants supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA). The grants are public health studies of behavioral factors involved in the transmission of HIV among sex workers and substance abuser populations in Thailand, China, and Russia. The ATS opposed this amendment in a letter to House Representatives on the basis of support for the NIH scientific peer-review process without interference from Congress.

The Senate Labor-HHS-Education Appropriations Subcommittee is scheduled to mark up its version of the health spending bill this week. It is not yet known if an amendment similar to the Issa measure will be offered in the Senate bill, which would be necessary for it to be enacted into law.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria